Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: The diabetes surgery study randomized clinical trial

JAMA

Volumn 309, Issue 21, 2013, Pages 2240-2249

  Ikramuddin, Sayeed ^a   Korner, Judith ^d   Lee, Wei Jei ^e   Connett, John E ^b   Inabnet III, William B ^f   Billington, Charles J ^a   Thomas, Avis J ^b   Leslie, Daniel B ^a   Chong, Keong ^g   Jeffery, Robert W ^b   Ahmed, Leaque ^d   Vella, Adrian ^h   Chuang, Lee Ming ^e   Bessler, Marc ^d   Sarr, Michael G ^h   Swain, James M ⁱ   Laqua, Patricia ^c   Jensen, Michael D ^h   Bantle, John P ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g MIN SHENG GENERAL HOSPITAL   (Taiwan)

^h MAYO CLINIC   (United States)

ⁱ Virginia G Piper Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ADVERSE OUTCOME; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; COMORBIDITY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOGLYCEMIA; INTERMETHOD COMPARISON; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL DEFICIENCY; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; ROUX Y ANASTOMOSIS; STOMACH BYPASS; SYSTOLIC BLOOD PRESSURE; TAIWAN; TEACHING HOSPITAL; UNITED STATES; WEIGHT REDUCTION;

EID: 84878534607     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.5835     Document Type: Article

References (25)

1. American Diabetes Association. Standards of medical care in diabetes - 2013. Diabetes Care. 2013;36(suppl 1):S11-S66.
2. Wing RR; Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566-1575.
3. Wong K, Glovaci D, Malik S, et al. Comparison of demographic factors and cardiovascular risk factor control among US adults with type 2 diabetes by insulin treatment classification. J Diabetes Complications. 2012;26(3):169-174.
4. Sjöström L, Lindroos AK, Peltonen M, et al Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683-2693. (Pubitemid 39665322)
5. Sjöström L, Narbro K, Sjöström CD, et al Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741-752. (Pubitemid 47295641)
6. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316-323. (Pubitemid 351159368)
7. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577-1585.
8. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery vs intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567-1576.
9. Ludwig DS, Ebbeling CB, Livingston EH. Surgical vs lifestyle treatment for type 2 diabetes. JAMA. 2012;308(10):981-982.
10. Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254(3):410-420.
11. Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25(12):2165-2171.
12. Ikramuddin S, Kendrick ML, Kellogg TA, Sarr MG. Open and laparoscopic Roux-en-Y gastric bypass: our techniques. J Gastrointest Surg. 2007;11(2):217-228.
13. American Diabetes Association. Standards of medical care in diabetes - 2009. Diabetes Care. 2009;32(suppl 1):S13-S61.
14. Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991;10(4):585-598.
15. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467-484.
16. Pi-Sunyer X, Blackburn G, Brancati FL, et al Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007;30(6):1374-1383. (Pubitemid 46871141)
17. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986.
18. Nathan DM, Cleary PA, Backlund J-YC, et al Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643-2653. (Pubitemid 41817713)
19. Bertoni AG, Clark JM, Feeney P, et al Look AHEAD Research Group. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study. J Diabetes Complications. 2008;22(1):1-9.
20. Carlsson LMS, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695-704.
21. Thaler JP, Cummings DE. Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150(6):2518-2525.
22. DeMaria EJ, Sugerman HJ, Kellum JM, Meador JG, Wolfe LG. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg. 2002;235(5):640-645.
23. Dixon JB, Zimmet P, Alberti KG, Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med. 2011;28(6):628-642.
24. Ryan DH. BMI guidelines for bariatric surgery in diabetes: how low can we go? Diabetes Care. 2012;35(7):1399-1400.
25. DiGiorgi M, Rosen DJ, Choi JJ, et al. Reemergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010;6(3):249-253.